PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.\', \'Center of Metabolism and Inflammation, Division of Medicine, Royal Free Campus, University College London, Rowland Hill Road, London, NW3 2PF, UK.\', \'Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar.\', \'Biomedical Research Center, Qatar University, P.O. Box 2713, Doha, Qatar.\', \'Communicable Disease Center (CDC) and the Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.\', \'Hezm Mebairek General Hospital, Hamad Medical Corporation, Doha, Qatar.\', \'Anti-Doping Laboratory Qatar, Doha, Qatar.\', \'Aspetar Hospital, Orthopaedic and Sports Medicine Hospital, FIFA Medical Centre of Excellence, Doha, Qatar.\', \'Royal College of Surgeons of Ireland in Bahrain, PO Box 15503, Adliya, Bahrain.\', \'College of Health and Life Sciences (CHLS), Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar.\', \'Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar. FAlEjeh@hbku.edu.qa.\', \'College of Health and Life Sciences (CHLS), Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar. FAlEjeh@hbku.edu.qa.\', \'Faculty of Medicine, University of Queensland, St Lucia, QLD, 4072, Australia. FAlEjeh@hbku.edu.qa.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41467-022-28639-4
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 35177642
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all